# Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)

> **NCT02797626** · PHASE2 · UNKNOWN · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 30 (estimated)

## Conditions studied

- Stage II A/B Seminomatous Germ Cell Tumors

## Interventions

- **PROCEDURE:** Primary retroperitoneal lymph-node dissection (pRPLND)

## Key facts

- **NCT ID:** NCT02797626
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02797626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02797626, "Trial to Evaluate Progression Free Survival With Primary Retroperitoneal Lymph-node Dissection (pRPLND) Only in Patients With Seminomatous Testicular Germ Cell Tumors With Clinical Stage IIA/B (PRIMETEST)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02797626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*